Sign Up to like & get
recommendations!
0
Published in 2022 at "Chinese Medical Journal"
DOI: 10.1097/cm9.0000000000002012
Abstract: Systemic therapy and transcatheter arterial chemoembolization (TACE) are the options recommended by the Chinese treatment guidelines for patients with HCCIVCTT. Tyrosine kinase inhibitors, such as lenvatinib, have been approved as first-line systemic therapies for advanced…
read more here.
Keywords:
resection patients;
patients hepatocellular;
tumor;
tumor thrombus ... See more keywords